ESR1 and breast cancer: For all tumour specimens analyzed, full histopathological and clinical follow-up data were available, allowing uni- and multivariate analyses of nuclear YB-1 expression in correlation to well-established factors of breast cancer prognosis (grade, nodal status, HER2, estrogen receptor (ER) status, progesterone receptor (PR) status).